CN114306184A - Preparation method of baby wet tissue with sterilizing and moisturizing core - Google Patents
Preparation method of baby wet tissue with sterilizing and moisturizing core Download PDFInfo
- Publication number
- CN114306184A CN114306184A CN202111649015.7A CN202111649015A CN114306184A CN 114306184 A CN114306184 A CN 114306184A CN 202111649015 A CN202111649015 A CN 202111649015A CN 114306184 A CN114306184 A CN 114306184A
- Authority
- CN
- China
- Prior art keywords
- wet tissue
- baby
- sterilizing
- stirring
- following
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000003020 moisturizing effect Effects 0.000 title claims abstract description 50
- 238000002360 preparation method Methods 0.000 title claims abstract description 36
- 230000001954 sterilising effect Effects 0.000 title claims abstract description 26
- 238000006243 chemical reaction Methods 0.000 claims abstract description 24
- 239000004744 fabric Substances 0.000 claims description 63
- 238000003756 stirring Methods 0.000 claims description 49
- 239000007788 liquid Substances 0.000 claims description 48
- 239000003814 drug Substances 0.000 claims description 37
- 239000004745 nonwoven fabric Substances 0.000 claims description 29
- 239000000017 hydrogel Substances 0.000 claims description 21
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 238000002791 soaking Methods 0.000 claims description 15
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 14
- 229920000742 Cotton Polymers 0.000 claims description 14
- 239000003054 catalyst Substances 0.000 claims description 14
- 239000003431 cross linking reagent Substances 0.000 claims description 13
- 239000004094 surface-active agent Substances 0.000 claims description 12
- 229930003231 vitamin Natural products 0.000 claims description 11
- 239000011782 vitamin Substances 0.000 claims description 11
- 229940088594 vitamin Drugs 0.000 claims description 11
- 235000013343 vitamin Nutrition 0.000 claims description 11
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 11
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 9
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 7
- 229930003427 Vitamin E Natural products 0.000 claims description 7
- 239000011248 coating agent Substances 0.000 claims description 7
- 238000000576 coating method Methods 0.000 claims description 7
- 238000005520 cutting process Methods 0.000 claims description 7
- 238000001704 evaporation Methods 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 7
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 7
- 239000012535 impurity Substances 0.000 claims description 7
- 238000011068 loading method Methods 0.000 claims description 7
- 238000003760 magnetic stirring Methods 0.000 claims description 7
- 238000004806 packaging method and process Methods 0.000 claims description 7
- QGWDKKHSDXWPET-UHFFFAOYSA-E pentabismuth;oxygen(2-);nonahydroxide;tetranitrate Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[O-2].[Bi+3].[Bi+3].[Bi+3].[Bi+3].[Bi+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O QGWDKKHSDXWPET-UHFFFAOYSA-E 0.000 claims description 7
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 7
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 7
- 238000000746 purification Methods 0.000 claims description 7
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical group [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 claims description 7
- 229940046009 vitamin E Drugs 0.000 claims description 7
- 235000019165 vitamin E Nutrition 0.000 claims description 7
- 239000011709 vitamin E Substances 0.000 claims description 7
- 238000005303 weighing Methods 0.000 claims description 7
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 claims description 5
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 claims description 5
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 5
- 229940069521 aloe extract Drugs 0.000 claims description 5
- 229960000686 benzalkonium chloride Drugs 0.000 claims description 5
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 5
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 239000000811 xylitol Substances 0.000 claims description 5
- 235000010447 xylitol Nutrition 0.000 claims description 5
- 229960002675 xylitol Drugs 0.000 claims description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 4
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 claims description 4
- 229960001927 cetylpyridinium chloride Drugs 0.000 claims description 4
- NFCRBQADEGXVDL-UHFFFAOYSA-M cetylpyridinium chloride monohydrate Chemical compound O.[Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 NFCRBQADEGXVDL-UHFFFAOYSA-M 0.000 claims description 4
- MXOAEAUPQDYUQM-UHFFFAOYSA-N chlorphenesin Chemical compound OCC(O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-UHFFFAOYSA-N 0.000 claims description 4
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- 229940104261 taurate Drugs 0.000 claims description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 4
- YLGYACDQVQQZSW-UHFFFAOYSA-N n,n-dimethylprop-2-enamide Chemical compound CN(C)C(=O)C=C YLGYACDQVQQZSW-UHFFFAOYSA-N 0.000 claims description 3
- 239000004971 Cross linker Substances 0.000 claims description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 8
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 claims 1
- 244000005700 microbiome Species 0.000 abstract description 7
- 210000000170 cell membrane Anatomy 0.000 abstract description 4
- 210000004027 cell Anatomy 0.000 abstract description 3
- 230000000694 effects Effects 0.000 abstract description 3
- 230000002401 inhibitory effect Effects 0.000 abstract description 2
- 230000004060 metabolic process Effects 0.000 abstract description 2
- 230000036632 reaction speed Effects 0.000 abstract description 2
- 230000007613 environmental effect Effects 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- BQMNFPBUAQPINY-UHFFFAOYSA-N azane;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid Chemical compound [NH4+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C BQMNFPBUAQPINY-UHFFFAOYSA-N 0.000 description 4
- XIWFQDBQMCDYJT-UHFFFAOYSA-M benzyl-dimethyl-tridecylazanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 XIWFQDBQMCDYJT-UHFFFAOYSA-M 0.000 description 4
- 239000003906 humectant Substances 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 239000002260 anti-inflammatory agent Substances 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- MXOAEAUPQDYUQM-QMMMGPOBSA-N (S)-chlorphenesin Chemical compound OC[C@H](O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-QMMMGPOBSA-N 0.000 description 1
- OBFSQMXGZIYMMN-UHFFFAOYSA-N 3-chloro-2-hexadecylpyridine Chemical compound CCCCCCCCCCCCCCCCC1=NC=CC=C1Cl OBFSQMXGZIYMMN-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012444 Dermatitis diaper Diseases 0.000 description 1
- 208000003105 Diaper Rash Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 229960003993 chlorphenesin Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- -1 diphenyl ethylene compound Chemical class 0.000 description 1
- 125000004050 enoyl group Chemical group 0.000 description 1
- 229940100524 ethylhexylglycerin Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Cosmetics (AREA)
Abstract
The invention relates to the technical field of sterilizing and moisturizing wet tissues, in particular to a preparation method of a baby wet tissue with a sterilizing and moisturizing core; according to the preparation method of the infant wet wipe with the sterilizing and moisturizing core, the integrity of the cell membrane is damaged by changing the surface tension of the cell membrane of the microorganism, and the growth and metabolism of the microorganism cell are intervened, so that the effect of inhibiting the growth of the microorganism is achieved, and the infant wet wipe with the sterilizing and moisturizing core has the advantages of environmental friendliness, biological inertia and controllable reaction speed of reaction, lays a good foundation for the application of the infant wet wipe with the sterilizing and moisturizing core, and has excellent stability.
Description
The invention relates to the technical field of sterilization and moisturizing wet tissues, in particular to a preparation method of a baby wet tissue with a sterilization and moisturizing core.
Background
Disposable wet wipes generally comprise a liquid pervious topsheet facing the body of the wearer, a liquid impervious backsheet facing the garments of the wearer, a moisturizing core disposed between the liquid pervious topsheet and the backsheet, and means for securing the moisturizing core in a fixed relationship with respect to the body of the wearer, the moisturizing core serving as the liquid retention area for the wet wipe.
The baby wet tissue is mainly used for cleaning the buttocks of a baby or wiping the face to prevent diaper rash, psoriasis or skin allergy. The baby wet tissue is generally added with an antibacterial agent to have a certain antibacterial function.
CN104523457A provides an antibiotic and anti-inflammatory baby wet tissue, which is formed by soaking non-woven fabrics in wet tissue liquid medicine, wherein the wet tissue liquid medicine comprises the following components in parts by weight: 90-95 parts of RO pure water, 1-3 parts of humectant, 0.3-0.5 part of preservative, 0.5-3.5 parts of antibacterial and anti-inflammatory agent, 0.1-2 parts of surfactant and 0.1-1 part of skin care agent; the antibacterial and anti-inflammatory agent is a mixture of chitosan quaternary ammonium salt and polyhydroxy diphenyl ethylene compound. The invention also discloses a preparation method of the antibacterial and anti-inflammatory baby wet tissue. The antibacterial and anti-inflammatory baby wet tissue provided by the invention has good antibacterial and anti-inflammatory performances, is high in safety and does not influence the health of a baby.
The alcohol solvent of the disposable wet tissue volatilizes, and people feel dry after wiping, so that further improvement is needed.
Disclosure of Invention
Aiming at the problems, the invention discloses a preparation method of a baby wet tissue with a sterilizing and moisturizing core, and belongs to the technical field of sterilizing and moisturizing wet tissues.
A preparation method of a baby wet tissue with a sterilizing and moisturizing core is characterized by comprising the following steps:
s1: the external package of the non-woven fabrics and the internal package bag is clear and is disinfected so as to be sent to a purification workshop for use.
S2: preparation of wet tissue liquid medicine
The wet tissue liquid medicine comprises the following components:
| serial number | Chemical name | Mass percent% | CAS number |
| 1 | Chlorophytidine ester | 0.01-0.07 | 104-29-0 |
| 2 | Ethyl hexyl glycerol | 0.01-0.07 | 70445-33-9 |
| 3 | Aloe extract | 0.01-0.05 | 8001-97-6 |
| 4 | Cetyl pyridinium chloride | 0.01-0.05 | 6004-24-6 |
| 5 | Benzalkonium chloride | 0.006-0.07 | 8001-54-5 |
| 6 | Dipropylene glycol | 0.05-0.3 | 25265-71-8 |
| 7 | Citric acid | 0.05-0.3 | 77-92-9 |
| 8 | Surface active agent | 0.05-0.3 | 9005-64-5 |
| 9 | Xylitol, its preparation method and use | 0.05-0.3 | 87-99-0 |
| 10 | Vitamin preparation | 0.05-0.3 | 7695-91-2 |
| 11 | Hydrogel modulators | 0.1-0.8％ | -- |
| 12 | Pure water | Balance of | 7732-18-5 |
| Total of | 100％ |
Weighing corresponding liquid medicine according to a formula table, and reweighing to ensure the consistency of the formula; stirring for 1-3 hours; then adding pure water, continuously stirring for 3-6 hours to fully dissolve the liquid medicine, and filtering to remove impurity components in the solution;
s3: cloth feeding: the cutting length of the base cloth is set according to the product requirement, and the folding width size is adjusted.
Opening a liquid supply power switch and a stirrer switch in the folding electromechanical box; checking the weight, the size, the humidifying uniformity, the fluffing at the cut part and other items of the unpacked single-package product according to the product specification; loading the non-woven fabric on a machine, and performing necessary folding on the non-woven fabric by the machine; when the base cloth is not stably folded or the base cloth width is obviously narrowed, the tension of the base cloth can be changed by adjusting the tension of the base cloth, so that the base cloth can stably run and the base cloth width is not narrowed.
S4: combined soaking of the medicinal cloth:
and (3) coating the high-fluffy cotton layer with non-woven fabrics, soaking the high-fluffy cotton layer with the solution to prepare a moisturizing core, stirring the moisturizing core for 1 to 3 hours, and packaging the moisturizing core to obtain the product.
More preferably, the preparation method of the hydrogel regulator comprises the following steps:
adding 10-15 parts of dimercapto cross-linking agent, 8-15 parts of acryloyl dimethyl ammonium taurate and 2-5 parts of catalyst into 100-200 parts of cosmetic white oil, and evaporating the white oil after the reaction is finished to obtain a hydrogel regulator;
more preferably, the dimercapto crosslinker is selected from one of the following: dimercaptopolyethylene glycol, dithiothreitol;
more preferably, the catalyst is sodium ethoxide;
more preferably, the reaction condition is that the stirring reaction is carried out for 80-150min under the temperature controlled at 70-80 ℃;
more preferably, the stirring is magnetic stirring, and the stirring speed is 320-;
more preferably, the stirring temperature of the wet tissue liquid medicine is 20-30 ℃;
more preferably, the vitamin is vitamin E;
more preferably, the surfactant is tween 20.
The reaction mechanism is as follows:
ethylhexyl glycerin of the present invention: it can interfere with interfacial tension, making some active ingredients or preservatives more accessible to microbial cells. The integrity of the cell membrane is damaged by changing the surface tension of the cell membrane of the microorganism, and the growth and metabolism of microorganism cells are interfered, so that the effect of inhibiting the growth of the microorganism is achieved;
the xylitol or the dipropylene glycol is used as a humectant.
The benzalkonium chloride of the present invention is antibiotic antiphlogistic.
The amino acid humectant or the glycerol is the humectant.
The invention relates to cetyl pyridine chloride or chlorphenesin and ethylhexyl glycerol as a preservative.
The aloe extract of the invention is a skin care agent.
The hydrogel regulator adopts a double mercapto crosslinking agent and acryloyl dimethyl ammonium taurate to carry out addition reaction, so that the hydrogel regulator can be obtained.
The technical effects are as follows:
the invention has the advantages of environment-friendly reaction, biological inertia and controllable reaction speed, lays a good foundation for the application of the hydrogel and has excellent stability.
Drawings
FIG. 1 is a flow chart of a wet towel production process.
Detailed Description
The invention will be described in detail with reference to the following preferred embodiments, but the invention is not limited thereto:
example 1
A preparation method of a baby wet tissue with a sterilizing and moisturizing core is characterized by comprising the following steps:
s1: the external package of the non-woven fabrics and the internal package bag is clear and is disinfected so as to be sent to a purification workshop for use.
S2: preparation of wet tissue liquid medicine
The wet tissue liquid medicine comprises the following components:
| serial number | Chemical name | Mass kg | CAS number |
| 1 | Chlorophytidine ester | 0.03 | 104-29-0 |
| 2 | Ethyl hexyl glycerol | 0.02 | 70445-33-9 |
| 3 | Aloe extract | 0.02 | 8001-97-6 |
| 4 | Cetyl pyridinium chloride | 0.01 | 6004-24-6 |
| 5 | Benzalkonium chloride | 0.018 | 8001-54-5 |
| 6 | Dipropylene glycol | 0.12 | 25265-71-8 |
| 7 | Citric acid | 0.18 | 77-92-9 |
| 8 | Surface active agent | 0.20 | 9005-64-5 |
| 9 | Xylitol, its preparation method and use | 0.08 | 87-99-0 |
| 10 | Vitamin preparation | 0.09 | 7695-91-2 |
| 11 | Hydrogel modulators | 0.3 | -- |
| 12 | Pure water | Balance of | 7732-18-5 |
| Total of | 100 |
Weighing corresponding liquid medicine according to a formula table, and reweighing to ensure the consistency of the formula; stirring for 2 hours; then adding pure water, continuously stirring for 3 hours to fully dissolve the liquid medicine, and filtering to remove impurity components in the solution;
s3: cloth feeding: the cutting length of the base cloth is set according to the product requirement, and the folding width size is adjusted.
Opening a liquid supply power switch and a stirrer switch in the folding electromechanical box; checking the weight, the size, the humidifying uniformity, the fluffing at the cut part and other items of the unpacked single-package product according to the product specification; loading the non-woven fabric on a machine, and performing necessary folding on the non-woven fabric by the machine; when the base cloth is not stably folded or the base cloth width is obviously narrowed, the tension of the base cloth can be changed by adjusting the tension of the base cloth, so that the base cloth can stably run and the base cloth width is not narrowed.
S4: combined soaking of the medicinal cloth:
and (3) coating the high-fluffy cotton layer with non-woven fabrics, soaking the high-fluffy cotton layer with the solution to prepare a moisturizing core, stirring the moisturizing core for 2 hours, and packaging the moisturizing core to obtain the product.
The preparation method of the hydrogel regulator comprises the following steps:
adding 10g of dimercapto cross-linking agent, 8g of ammonium acryloyl dimethyl taurate and 2g of catalyst into 100g of cosmetic white oil, and evaporating the white oil after the reaction is finished to obtain a hydrogel regulator;
the dimercapto cross-linking agent is dimercapto polyethylene glycol;
the catalyst is sodium ethoxide;
the reaction condition is that the temperature is controlled to be 70 ℃ and the stirring reaction is carried out for 120 min;
the stirring is magnetic stirring, and the stirring speed is 320 r/min;
the stirring temperature of the wet tissue liquid medicine is 20 ℃;
the vitamin is vitamin E;
the surfactant is tween 20.
Example 2
A preparation method of a baby wet tissue with a sterilizing and moisturizing core is characterized by comprising the following steps:
s1: the external package of the non-woven fabrics and the internal package bag is clear and is disinfected so as to be sent to a purification workshop for use.
S2: preparation of wet tissue liquid medicine
The wet tissue liquid medicine comprises the following components:
| serial number | Chemical name | Mass kg | CAS number |
| 1 | Chlorophytidine ester | 0.05 | 104-29-0 |
| 2 | Ethyl hexyl glycerol | 0.02 | 70445-33-9 |
| 3 | Aloe extract | 0.04 | 8001-97-6 |
| 4 | Cetyl pyridinium chloride | 0.03 | 6004-24-6 |
| 5 | Benzalkonium chloride | 0.03 | 8001-54-5 |
| 6 | Dipropylene glycol | 0.10 | 25265-71-8 |
| 7 | Citric acid | 0.05-0.3 | 77-92-9 |
| 8 | Surface active agent | 0.16 | 9005-64-5 |
| 9 | Xylitol, its preparation method and use | 0.12 | 87-99-0 |
| 10 | Vitamin preparation | 0.20 | 7695-91-2 |
| 11 | Hydrogel modulators | 0.20 | -- |
| 12 | Pure water | Balance of | 7732-18-5 |
| Total of | 100 |
Weighing corresponding liquid medicine according to a formula table, and reweighing to ensure the consistency of the formula; stirring for 2 hours; then adding pure water, continuously stirring for 4 hours to fully dissolve the liquid medicine, and filtering to remove impurity components in the solution;
s3: cloth feeding: the cutting length of the base cloth is set according to the product requirement, and the folding width size is adjusted.
Opening a liquid supply power switch and a stirrer switch in the folding electromechanical box; checking the weight, the size, the humidifying uniformity, the fluffing at the cut part and other items of the unpacked single-package product according to the product specification; loading the non-woven fabric on a machine, and performing necessary folding on the non-woven fabric by the machine; when the base cloth is not stably folded or the base cloth width is obviously narrowed, the tension of the base cloth can be changed by adjusting the tension of the base cloth, so that the base cloth can stably run and the base cloth width is not narrowed.
S4: combined soaking of the medicinal cloth:
and (3) coating the high-fluffy cotton layer with non-woven fabrics, soaking the high-fluffy cotton layer with the solution to prepare a moisturizing core, stirring the moisturizing core for 2 hours, and packaging the moisturizing core to obtain the product.
The preparation method of the hydrogel regulator comprises the following steps:
adding 11g of dimercapto cross-linking agent, 9g of enoyl dimethyl ammonium taurate and 2g of catalyst into 120g of cosmetic white oil, and evaporating the white oil after the reaction is finished to obtain a hydrogel regulator;
the dimercapto cross-linking agent is dimercapto polyethylene glycol;
the catalyst is sodium ethoxide;
the reaction condition is that the temperature is controlled to be 72 ℃ and the stirring reaction is carried out for 100 min;
the stirring is magnetic stirring, and the stirring speed is 320 r/min;
the stirring temperature of the wet tissue liquid medicine is 20 ℃;
the vitamin is vitamin E;
the surfactant is tween 20.
Example 3
A preparation method of a baby wet tissue with a sterilizing and moisturizing core is characterized by comprising the following steps:
s1: the external package of the non-woven fabrics and the internal package bag is clear and is disinfected so as to be sent to a purification workshop for use.
S2: preparation of wet tissue liquid medicine
The wet tissue liquid medicine comprises the following components:
weighing corresponding liquid medicine according to a formula table, and reweighing to ensure the consistency of the formula; stirring for 3 hours; then adding pure water, continuously stirring for 3 hours to fully dissolve the liquid medicine, and filtering to remove impurity components in the solution;
s3: cloth feeding: the cutting length of the base cloth is set according to the product requirement, and the folding width size is adjusted.
Opening a liquid supply power switch and a stirrer switch in the folding electromechanical box; checking the weight, the size, the humidifying uniformity, the fluffing at the cut part and other items of the unpacked single-package product according to the product specification; loading the non-woven fabric on a machine, and performing necessary folding on the non-woven fabric by the machine; when the base cloth is not stably folded or the base cloth width is obviously narrowed, the tension of the base cloth can be changed by adjusting the tension of the base cloth, so that the base cloth can stably run and the base cloth width is not narrowed.
S4: combined soaking of the medicinal cloth:
and (3) coating the high-fluffy cotton layer with non-woven fabrics, soaking the high-fluffy cotton layer with the solution to prepare a moisturizing core, stirring the moisturizing core for 1 hour, and packaging the moisturizing core to obtain the product.
More preferably, the preparation method of the hydrogel regulator comprises the following steps:
adding 12g of dimercapto cross-linking agent, 10g of ammonium acryloyl dimethyl taurate and 3g of catalyst into 140g of cosmetic white oil, and evaporating the white oil after the reaction is finished to obtain a hydrogel regulator;
the dimercapto cross-linking agent is dithiothreitol;
the catalyst is sodium ethoxide;
the reaction condition is that the temperature is controlled to be 76 ℃ and the stirring reaction is carried out for 90 min;
the stirring is magnetic stirring, and the stirring speed is 320 r/min;
the stirring temperature of the wet tissue liquid medicine is 26 ℃;
the vitamin is vitamin E;
the surfactant is tween 20.
Example 4
A preparation method of a baby wet tissue with a sterilizing and moisturizing core is characterized by comprising the following steps:
s1: the external package of the non-woven fabrics and the internal package bag is clear and is disinfected so as to be sent to a purification workshop for use.
S2: preparation of wet tissue liquid medicine
The wet tissue liquid medicine comprises the following components:
weighing corresponding liquid medicine according to a formula table, and reweighing to ensure the consistency of the formula; stirring for 2 hours; then adding pure water, continuously stirring for 4 hours to fully dissolve the liquid medicine, and filtering to remove impurity components in the solution;
s3: cloth feeding: the cutting length of the base cloth is set according to the product requirement, and the folding width size is adjusted.
Opening a liquid supply power switch and a stirrer switch in the folding electromechanical box; checking the weight, the size, the humidifying uniformity, the fluffing at the cut part and other items of the unpacked single-package product according to the product specification; loading the non-woven fabric on a machine, and performing necessary folding on the non-woven fabric by the machine; when the base cloth is not stably folded or the base cloth width is obviously narrowed, the tension of the base cloth can be changed by adjusting the tension of the base cloth, so that the base cloth can stably run and the base cloth width is not narrowed.
S4: combined soaking of the medicinal cloth:
and (3) coating the high-fluffy cotton layer with non-woven fabrics, soaking the high-fluffy cotton layer with the solution to prepare a moisturizing core, stirring the moisturizing core for 3 hours, and packaging the moisturizing core to obtain the product.
The preparation method of the hydrogel regulator comprises the following steps:
adding 14g of dimercapto cross-linking agent, 12g of ammonium acryloyl dimethyl taurate and 4g of catalyst into 160g of cosmetic white oil, and evaporating the white oil after the reaction is finished to obtain a hydrogel regulator;
the dimercapto cross-linking agent is dithiothreitol;
the catalyst is sodium ethoxide;
the reaction condition is that the temperature is controlled to be 76 ℃ and the stirring reaction is carried out for 130 min;
the stirring is magnetic stirring, and the stirring speed is 480 r/min;
the stirring temperature of the wet tissue liquid medicine is 26 ℃;
the vitamin is vitamin E;
the surfactant is tween 20.
Example 5
A preparation method of a baby wet tissue with a sterilizing and moisturizing core is characterized by comprising the following steps:
s1: the external package of the non-woven fabrics and the internal package bag is clear and is disinfected so as to be sent to a purification workshop for use.
S2: preparation of wet tissue liquid medicine
The wet tissue liquid medicine comprises the following components:
weighing corresponding liquid medicine according to a formula table, and reweighing to ensure the consistency of the formula; stirring for 3 hours; then adding pure water, continuously stirring for 3 hours to fully dissolve the liquid medicine, and filtering to remove impurity components in the solution;
s3: cloth feeding: the cutting length of the base cloth is set according to the product requirement, and the folding width size is adjusted.
Opening a liquid supply power switch and a stirrer switch in the folding electromechanical box; checking the weight, the size, the humidifying uniformity, the fluffing at the cut part and other items of the unpacked single-package product according to the product specification; loading the non-woven fabric on a machine, and performing necessary folding on the non-woven fabric by the machine; when the base cloth is not stably folded or the base cloth width is obviously narrowed, the tension of the base cloth can be changed by adjusting the tension of the base cloth, so that the base cloth can stably run and the base cloth width is not narrowed.
S4: combined soaking of the medicinal cloth:
and (3) coating the high-fluffy cotton layer with non-woven fabrics, soaking the high-fluffy cotton layer with the solution to prepare a moisturizing core, stirring the moisturizing core for 2 hours, and packaging the moisturizing core to obtain the product.
The preparation method of the hydrogel regulator comprises the following steps:
adding 12g of dimercapto cross-linking agent, 15g of ammonium acryloyl dimethyl taurate and 5g of catalyst into 200g of cosmetic white oil, and evaporating the white oil after the reaction is finished to obtain a hydrogel regulator;
the dimercapto cross-linking agent is dimercapto polyethylene glycol;
the catalyst is sodium ethoxide;
the reaction condition is that the temperature is controlled to be 80 ℃ and the stirring reaction is carried out for 90 min;
the stirring is magnetic stirring, and the stirring speed is 480 r/min;
the stirring temperature of the wet tissue liquid medicine is 26 ℃;
the vitamin is vitamin E;
the surfactant is tween 20.
The test method comprises the following steps:
reference to the microbial testing of USP-NF non-sterile products: detecting microbial count; microbiological testing of USP-NF non-sterile products: detection of specific microorganisms.
Table 1 test results of examples
Claims (9)
1. A preparation method of a baby wet tissue with a sterilizing and moisturizing core comprises the following operation steps:
s1: the external package of the non-woven fabrics and the internal package bag is clear and is disinfected so as to be sent to a purification workshop for use.
S2: preparation of wet tissue liquid medicine
The wet tissue liquid medicine comprises the following components:
Weighing corresponding liquid medicine according to a formula table, and reweighing to ensure the consistency of the formula; stirring for 1-3 hours; then adding pure water, continuously stirring for 3-6 hours to fully dissolve the liquid medicine, and filtering to remove impurity components in the solution;
s3: cloth feeding: the cutting length of the base cloth is set according to the product requirement, and the folding width size is adjusted.
Opening a liquid supply power switch and a stirrer switch in the folding electromechanical box; checking the weight, the size, the humidifying uniformity, the fluffing at the cut part and other items of the unpacked single-package product according to the product specification; loading the non-woven fabric on a machine, and performing necessary folding on the non-woven fabric by the machine; when the base cloth is not stably folded or the base cloth width is obviously narrowed, the tension of the base cloth can be changed by adjusting the tension of the base cloth, so that the base cloth can stably run and the base cloth width is not narrowed.
S4: combined soaking of the medicinal cloth:
and (3) coating the high-fluffy cotton layer with non-woven fabrics, soaking the high-fluffy cotton layer with the solution to prepare a moisturizing core, stirring the moisturizing core for 1 to 3 hours, and packaging the moisturizing core to obtain the product.
2. The method for preparing the wet tissue for baby with sterilizing and moisturizing core as claimed in claim 1, wherein the wet tissue for baby is prepared by the following steps: the preparation method of the hydrogel regulator comprises the following steps:
adding 10-15 parts of dimercapto cross-linking agent, 8-15 parts of acryloyl dimethyl ammonium taurate and 2-5 parts of catalyst into 100-200 parts of cosmetic white oil, and evaporating the white oil after the reaction is finished to obtain the hydrogel regulator.
3. The method for preparing the wet tissue for baby with sterilizing and moisturizing core as claimed in claim 2, wherein the wet tissue for baby is prepared by the following steps: the dimercapto crosslinker is selected from one of the following substances: dimercaptopolyethylene glycol, dithiothreitol.
4. The method for preparing the wet tissue for baby with sterilizing and moisturizing core as claimed in claim 2, wherein the wet tissue for baby is prepared by the following steps: the catalyst is sodium ethoxide.
5. The method for preparing the wet tissue for baby with sterilizing and moisturizing core as claimed in claim 2, wherein the wet tissue for baby is prepared by the following steps: the reaction condition is that the temperature is controlled to be 70-80 ℃ and the stirring reaction is carried out for 80-150 min.
6. The method for preparing the wet tissue for baby with sterilizing and moisturizing core as claimed in claim 5, wherein the wet tissue for baby is prepared by the following steps: the stirring is magnetic stirring, and the stirring speed is 320-.
7. The method for preparing the wet tissue for baby with sterilizing and moisturizing core as claimed in claim 1, wherein the wet tissue for baby is prepared by the following steps: the stirring temperature of the wet tissue liquid medicine is 20-30 ℃.
8. The method for preparing the wet tissue for baby with sterilizing and moisturizing core as claimed in claim 1, wherein the wet tissue for baby is prepared by the following steps: the vitamin is vitamin E.
9. The method for preparing the wet tissue for baby with sterilizing and moisturizing core as claimed in claim 1, wherein the wet tissue for baby is prepared by the following steps: the surfactant is tween 20.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111649015.7A CN114306184B (en) | 2021-12-30 | 2021-12-30 | Preparation method of infant wet tissue with sterilization and moisturizing cores |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111649015.7A CN114306184B (en) | 2021-12-30 | 2021-12-30 | Preparation method of infant wet tissue with sterilization and moisturizing cores |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN114306184A true CN114306184A (en) | 2022-04-12 |
| CN114306184B CN114306184B (en) | 2023-07-25 |
Family
ID=81018687
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111649015.7A Active CN114306184B (en) | 2021-12-30 | 2021-12-30 | Preparation method of infant wet tissue with sterilization and moisturizing cores |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114306184B (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20140068708A (en) * | 2012-11-28 | 2014-06-09 | 한종우 | Sterilized wet tissue and manufacturing mehotd of the same |
| CN104523457A (en) * | 2014-11-13 | 2015-04-22 | 苏州威尔德工贸有限公司 | Antisepsis and anti-inflammation baby wet tissue and preparation method thereof |
| KR20150102578A (en) * | 2014-02-28 | 2015-09-07 | 우일씨앤텍(주) | Antibiotic wet tissue, and manufacturing method thereof |
| CN108066184A (en) * | 2017-12-29 | 2018-05-25 | 武汉芘芘薇莎生物科技有限公司 | A kind of preparation method of baby wipes |
| CN109692145A (en) * | 2019-03-13 | 2019-04-30 | 福建三达节能新材股份有限公司 | A kind of silk non-woven fabric of baby wipes and preparation method thereof |
| CN110742845A (en) * | 2019-11-26 | 2020-02-04 | 苏州东方之宝生物药业有限公司 | Wet tissue and preparation method thereof |
| CN111840182A (en) * | 2020-07-27 | 2020-10-30 | 支允前 | Multifunctional traditional Chinese medicine antibacterial sanitary wet tissue and preparation method thereof |
-
2021
- 2021-12-30 CN CN202111649015.7A patent/CN114306184B/en active Active
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20140068708A (en) * | 2012-11-28 | 2014-06-09 | 한종우 | Sterilized wet tissue and manufacturing mehotd of the same |
| KR20150102578A (en) * | 2014-02-28 | 2015-09-07 | 우일씨앤텍(주) | Antibiotic wet tissue, and manufacturing method thereof |
| CN104523457A (en) * | 2014-11-13 | 2015-04-22 | 苏州威尔德工贸有限公司 | Antisepsis and anti-inflammation baby wet tissue and preparation method thereof |
| CN108066184A (en) * | 2017-12-29 | 2018-05-25 | 武汉芘芘薇莎生物科技有限公司 | A kind of preparation method of baby wipes |
| CN109692145A (en) * | 2019-03-13 | 2019-04-30 | 福建三达节能新材股份有限公司 | A kind of silk non-woven fabric of baby wipes and preparation method thereof |
| CN110742845A (en) * | 2019-11-26 | 2020-02-04 | 苏州东方之宝生物药业有限公司 | Wet tissue and preparation method thereof |
| CN111840182A (en) * | 2020-07-27 | 2020-10-30 | 支允前 | Multifunctional traditional Chinese medicine antibacterial sanitary wet tissue and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 吴桃桃;: "婴儿湿巾的发展概述", 非织造布, vol. 16, no. 03, pages 10 - 12 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN114306184B (en) | 2023-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20060222675A1 (en) | Personal care compositions with color changing indicator | |
| EP3848014A1 (en) | Water-soluble fullerene topical composition | |
| EP2744474B1 (en) | Medicinal skin protection composition with an active ingredient combination which improves the skin barrier | |
| ES2698414T3 (en) | Composition for skin care | |
| CN106963658B (en) | A kind of cosmetic composition containing nanometer platinum | |
| CN106860029B (en) | Physical antibacterial wet tissue | |
| CN102127859B (en) | Spinning oil for degradable scaffold fiber for human body | |
| CN111249217A (en) | Cleansing liquid for adjusting skin micro-ecological balance and preparation method thereof | |
| KR20050084655A (en) | Antioxidant-containing wipes and absorbent products | |
| CN114401705A (en) | Kit for caring for keratin materials | |
| CN114306184A (en) | Preparation method of baby wet tissue with sterilizing and moisturizing core | |
| KR102243502B1 (en) | Stabilization Method of Dedifferentiated Plant Protoplast Complex With Active Material Insertion | |
| CN109528526A (en) | Plant essence skin conditioning agent and preparation method thereof and oil control and acne removal application | |
| KR101981590B1 (en) | Cosmetic composition for moisturizing containing Saururus chinensis fermented extract | |
| EP3311800B1 (en) | Composition comprising microstructures for the controlled release of ozonized oil | |
| JP4568892B2 (en) | Finishing method for textile products | |
| KR102426940B1 (en) | Liquid crystalline cosmetic composition | |
| CN107951746A (en) | A kind of micro-emulsion type disinfection bath foam and preparation method thereof | |
| CN115068353A (en) | Fullerene composition, preparation method and application thereof | |
| CN107375139A (en) | A kind of elastic force with senile-resistant efficacy compacts eye mask | |
| JP4707214B2 (en) | Skin preparation | |
| CN105708727A (en) | Moisture preserving, whitening and freckle and pox removing anti-bacterial dressing and preparing method thereof | |
| DE19950020A1 (en) | Use of compositions containing inhibitors of desmosome degradation to prevent skin-flaking during prophylactic or cosmetic treatment of dry skin | |
| CN115054552B (en) | Sapindus phosphate powder of salicylic acid and preparation method thereof | |
| CN118515575B (en) | Ammonium methyl cyclic acid salt and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |